Quest Diagnostics Incorporated (DGX)

Basic

  • Market Cap

    $15.43B

  • EV

    $20.31B

  • Shares Out

    112.43M

  • Revenue

    $9,297M

  • Employees

    44,500

Margins

  • Gross

    33.41%

  • EBITDA

    18.34%

  • Operating

    13.54%

  • Pre-Tax

    11%

  • Net

    8.21%

  • FCF

    6.41%

Returns (5Yr Avg)

  • ROA

    8.07%

  • ROE

    19.39%

  • ROCE

    14.86%

  • ROIC

    11.69%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $141.39

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $82.82

  • Earnings (Dil)

    $6.67

  • FCF

    $5.22

  • Book Value

    $57.37

Growth (CAGR)

  • Rev 3Yr

    3.6%

  • Rev 5Yr

    4.23%

  • Rev 10Yr

    2.64%

  • Dil EPS 3Yr

    -6.33%

  • Dil EPS 5Yr

    1.49%

  • Dil EPS 10Yr

    2.54%

  • Rev Fwd 2Yr

    -2.65%

  • EBITDA Fwd 2Yr

    -2.75%

  • EPS Fwd 2Yr

    -4.9%

  • EPS LT Growth Est

    -1.03%

Dividends

  • Yield

    —

  • Payout

    41.26%

  • DPS

    $2.79

  • DPS Growth 3Yr

    8.08%

  • DPS Growth 5Yr

    7.43%

  • DPS Growth 10Yr

    8.8%

  • DPS Growth Fwd 2Yr

    4.83%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

7,531.0

7,726.0

9,437.0

10,788.0

9,883.0

9,297.0

Total Revenues % Chg.

1.7%

2.6%

22.1%

14.3%

-8.4%

-9.7%

Cost of Goods Sold, Total

4,904.0

5,037.0

5,795.0

6,545.0

6,416.0

6,191.0

Gross Profit

2,627.0

2,689.0

3,642.0

4,243.0

3,467.0

3,106.0

Selling General & Admin Expenses, Total

1,395.0

1,457.0

1,545.0

1,696.0

1,818.0

1,748.0

Amortization of Goodwill and Intangible Assets

90.0

96.0

103.0

103.0

120.0

120.0

Other Operating Expenses

-2.0

-16.0

6.0

-2.0

-23.0

-21.0

Other Operating Expenses, Total

1,483.0

1,537.0

1,654.0

1,797.0

1,915.0

1,847.0

Operating Income

1,144.0

1,152.0

1,988.0

2,446.0

1,552.0

1,259.0

Interest Expense, Total

-169.0

-180.0

-166.0

-152.0

-148.0

-153.0

Interest And Investment Income

2.0

5.0

3.0

1.0

10.0

9.0

Net Interest Expenses

-167.0

-175.0

-163.0

-151.0

-138.0

-144.0

Income (Loss) On Equity Invest.

44.0

57.0

75.0

78.0

44.0

21.0

Other Non Operating Income (Expenses)

-8.0

20.0

76.0

16.0

-25.0

16.0

EBT, Excl. Unusual Items

1,013.0

1,054.0

1,976.0

2,389.0

1,433.0

1,152.0

Restructuring Charges

-51.0

—

-14.0

-61.0

-102.0

-104.0

Merger & Related Restructuring Charges

—

—

—

—

—

—

Gain (Loss) On Sale Of Investments

—

—

—

353.0

-30.0

—

Gain (Loss) On Sale Of Assets

-4.0

73.0

-3.0

—

—

—

Asset Writedown

—

—

—

—

-14.0

-14.0

Other Unusual Items

12.0

6.0

—

-4.0

-8.0

-11.0

EBT, Incl. Unusual Items

970.0

1,133.0

1,959.0

2,677.0

1,279.0

1,023.0

Income Tax Expense

182.0

247.0

460.0

597.0

264.0

204.0

Earnings From Continuing Operations

788.0

886.0

1,499.0

2,080.0

1,015.0

819.0

Earnings Of Discontinued Operations

—

20.0

—

—

—

—

Minority Interest

-52.0

-48.0

-68.0

-85.0

-69.0

-56.0

Net Income

736.0

858.0

1,431.0

1,995.0

946.0

763.0

Preferred Dividend and Other Adjustments

3.0

3.0

6.0

7.0

4.0

4.0

Net Income to Common Incl Extra Items

733.0

855.0

1,425.0

1,988.0

942.0

759.0

Net Income to Common Excl. Extra Items

733.0

835.0

1,425.0

1,988.0

942.0

759.0

Total Shares Outstanding

135.0

133.0

133.0

119.0

111.0

112.0

Weighted Avg. Shares Outstanding

136.0

134.0

134.0

125.0

116.0

112.3

Weighted Avg. Shares Outstanding Dil

139.0

136.0

136.0

128.0

118.0

114.3

EPS

5.4

6.4

10.6

15.9

8.1

6.8

EPS Diluted

5.3

6.3

10.5

15.6

8.0

6.7

EBITDA

1,453.0

1,481.0

2,349.0

2,854.0

1,989.0

1,705.0